Asset Details
Do you wish to reserve the book?
Structural insights into sphingosine-1-phosphate receptor activation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Structural insights into sphingosine-1-phosphate receptor activation
Do you wish to request the book?
Structural insights into sphingosine-1-phosphate receptor activation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Structural insights into sphingosine-1-phosphate receptor activation
2022
Overview
As a critical sphingolipid metabolite, sphingosine-1-phosphate (S1P) plays an essential role in immune and vascular systems. There are five S1P receptors, designated as S1PR1 to S1PR5, encoded in the human genome, and their activities are governed by endogenous S1P, lipid-like S1P mimics, or nonlipid-like therapeutic molecules. Among S1PRs, S1PR1 stands out due to its nonredundant functions, such as the egress of T and B cells from the thymus and secondary lymphoid tissues, making it a potential therapeutic target. However, the structural basis of S1PR1 activation and regulation by various agonists remains unclear. Here, we report four atomic resolution cryo-electron microscopy (cryo-EM) structures of Gi-coupled human S1PR1 complexes: bound to endogenous agonist d18:1 S1P, benchmark lipid-like S1P mimic phosphorylated Fingolimod [(S)-FTY720-P], or nonlipid-like therapeutic molecule CBP-307 in two binding modes. Our results revealed the similarities and differences of activation of S1PR1 through distinct ligands binding to the amphiphilic orthosteric pocket. We also proposed a two-step “shallow to deep” transition process of CBP-307 for S1PR1 activation. Both binding modes of CBP-307 could activate S1PR1, but from shallow to deep transition may trigger the rotation of the N-terminal helix of Gαi and further stabilize the complex by increasing the Gαi interaction with the cell membrane. We combine with extensive biochemical analysis and molecular dynamic simulations to suggest key steps of S1P binding and receptor activation. The above results decipher the common feature of the S1PR1 agonist recognition and activation mechanism and will firmly promote the development of therapeutics targeting S1PRs.
Publisher
National Academy of Sciences
Subject
/ Binding
/ Colitis, Ulcerative - drug therapy
/ FTY720
/ Genomes
/ GTP-Binding Protein alpha Subunits, Gi-Go - chemistry
/ Humans
/ Immunosuppressive Agents - therapeutic use
/ Lipids
/ Multiple Sclerosis - drug therapy
/ Organophosphates - chemistry
/ Organophosphates - pharmacology
/ Organophosphates - therapeutic use
/ Protein Conformation, alpha-Helical
/ Sphingosine - analogs & derivatives
/ Sphingosine - therapeutic use
/ Sphingosine 1 Phosphate Receptor Modulators - chemistry
/ Sphingosine 1 Phosphate Receptor Modulators - pharmacology
/ Sphingosine 1 Phosphate Receptor Modulators - therapeutic use
/ Sphingosine-1-Phosphate Receptors - agonists
